Clinical Trial: Antiviral Therapy in Decompensated Hepatitis C Virus (HCV) Cirrhosis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional



Official Title: Outcome of Decompensated Hepatitis C Virus-Related Cirrhotic Patients Treated With Peginterferon Alfa-2b and Ribavirin: Results of a Controlled Study

Brief Summary:

To evaluate:

  1. the impact of combined antiviral therapy (Peginterferon plus ribavirin) on natural history of patients affected with HCV decompensated cirrhosis, after sustained virological response. A controlled study.
  2. safety and efficacy of antiviral therapy in this population by using a statistically significally number of patients as controls.